Udg Healthcare PLC (LON:UDG)‘s stock had its “buy” rating reaffirmed by Goodbody in a research report issued on Thursday.

A number of other research firms have also recently commented on UDG. Numis Securities Ltd reissued an “add” rating and set a GBX 730 ($9.12) price target on shares of Udg Healthcare PLC in a report on Monday, October 24th. Jefferies Group boosted their price target on Udg Healthcare PLC from GBX 680 ($8.50) to GBX 720 ($9.00) and gave the company a “buy” rating in a report on Friday, September 30th. Davy Research reiterated an “outperform” rating on shares of Udg Healthcare PLC in a report on Monday, October 24th. Liberum Capital started coverage on Udg Healthcare PLC in a report on Thursday, October 27th. They issued a “buy” rating and a GBX 750 ($9.37) price target for the company. Finally, Stifel Nicolaus reiterated a “hold” rating and issued a GBX 620 ($7.75) price target on shares of Udg Healthcare PLC in a report on Wednesday, September 28th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Udg Healthcare PLC currently has an average rating of “Buy” and a consensus target price of GBX 692.50 ($8.65).

Analyst Recommendations for Udg Healthcare PLC (LON:UDG)

Shares of Udg Healthcare PLC (LON:UDG) opened at 629.78 on Thursday. Udg Healthcare PLC has a one year low of GBX 491.30 and a one year high of GBX 692.50. The firm has a 50-day moving average price of GBX 653.93 and a 200-day moving average price of GBX 615.09. The company’s market capitalization is GBX 1.55 billion.

In other news, insider Chris Corbin sold 90,849 shares of the company’s stock in a transaction on Monday, September 26th. The stock was sold at an average price of GBX 634 ($7.92), for a total transaction of £575,982.66 ($719,618.52).

ILLEGAL ACTIVITY WARNING: “Goodbody Reiterates Buy Rating for Udg Healthcare PLC (UDG)” was posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this report on another publication, it was stolen and reposted in violation of US and international copyright & trademark law. The correct version of this report can be viewed at https://www.thecerbatgem.com/2016/11/24/goodbody-reiterates-buy-rating-for-udg-healthcare-plc-udg.html.

About Udg Healthcare PLC

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries.

Receive News & Stock Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related stocks with our FREE daily email newsletter.